Clinical study of cefpimizole in obstetric and gynecologic infections.
The use of cefpimizole (AC-1370) in 11 patients with a variety of obstetric and gynecologic infections was studied. Although the activity of AC-1370 was found in vitro less eminent than those of currently employed antibiotic regimens, the overall clinical response was 82%. No side effects were found.